echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Ted Pharmaceuticals was awarded the honorary title of "Top Ten Public Interest Enterprises"

    Ted Pharmaceuticals was awarded the honorary title of "Top Ten Public Interest Enterprises"

    • Last Update: 2021-01-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 10, 2021, the 6th Medical Practitioners Summit was held in Beijing, hosted by the Chinese Physicians Association.
    In addition to continuing the past, this summit of medical professionals, in order to carry forward the spirit of anti-epidemic, the transmission of positive energy in the industry as the goal, ad hoc "tribute to anti-epidemic heroes" series of honors, to the epidemic under the protection of the well-being of the country's doctors and enterprises.
    Ted Pharmaceuticals won the "Top Ten Public Interest Enterprise Honors" of China Health Public Welfare Star.
    the first year, the outbreak of the epidemic, the country started the epidemic prevention and control of the resistance and rescue war.
    January 26, Zheng Xiangling, President of Zhengda Pharmaceuticals and Chairman of Ted Pharmaceuticals, donated 10 million yuan on behalf of China Biopharmaceutical Co., Ltd. to work with the Chinese Academy of Medical Sciences to promote emergency prevention and control of science and technology to help fight the battle against the new crown virus.
    At the same time, under the epidemic, as an important member of China's pharmaceutical industry, Beijing Ted Pharmaceutical Co., Ltd. the first time to respond positively to the war "epidemic", to protect the supply of drugs, all-round safety prevention and control, external emergency assistance line, carried out a series of continuous donations, a total of more than 4 million yuan, the company's safety prevention and control in place, all links run smoothly.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.